PF-AtlasClinical Trials › NCT03264950

Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients

Elastography · Not specified

Registry ID
NCT03264950
Phase
Not specified
Status
Unknown
Drug / intervention
Elastography
Sponsor
University of Manitoba
Start
2017-10-01
Enrollment
60
Locations
1

About this trial

Diagnosis of hepatic fibrosis is challenging as specific tests for detection of fibrosis in pediatric Cystic Fibrosis associated liver disease (CFALD) have not been developed and existing investigations do not correlate well with presence or severity of disease. Using a Liver biopsy it is difficult to diagnose this condition because of the patchy nature of the disease. Investigators intend to identify hepatic and pancreatic fibrosis in Cystic Fibrosis patients using Elastography and correlate this with their biochemical markers as well as histological findings of patients who have undergone liver biopsy for diagnosis of CFALD.

View NCT03264950 on ClinicalTrials.gov →

Explore related

Related trials

Medical disclaimer. This page summarizes public trial data for NCT03264950 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.